Halozyme Therapeutics
HALO
#2469
Rank
NZ$9.93 B
Marketcap
$78.13
Share price
-15.02%
Change (1 day)
16.44%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): NZ$0.77 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$0.94 Billion. In 2023 the company made an earning of NZ$0.59 Billion, an increase over its 2022 earnings that were of NZ$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.77 B30.47%
2023 NZ$0.59 B39.94%
2022 NZ$0.42 B0.16%
2021 NZ$0.42 B92.2%
2020 NZ$0.22 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.14 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.18 Billion216.03%
2015 -NZ$54.92 Million-52.86%
2014 -NZ$0.12 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$91.25 Million169.94%
2011 -NZ$33.81 Million-63.44%
2010 -NZ$92.45 Million-7.19%
2009 -NZ$99.61 Million15.91%
2008 -NZ$85.94 Million83.89%
2007 -NZ$46.74 Million78.1%
2006 -NZ$26.24 Million16%
2005 -NZ$22.62 Million45.24%
2004 -NZ$15.58 Million682.42%
2003 -NZ$2 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$23.65 M-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.29 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.13 Billion-115.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.07 Billion-352.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.62 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$31.34 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA